Effects of Repetitive Transcranial Magnetic Stimulation on Cerebral Autoregulation in Patients With Acute Ischemic Stroke
Transcranial Magnetic Stimulation
About this trial
This is an interventional treatment trial for Transcranial Magnetic Stimulation
Eligibility Criteria
Inclusion Criteria: Age ≥ 18 years, both sexes; Clinically definite diagnosis of acute ischemic stroke; Baseline National Institute of Health Stroke Scale (NIHSS) score ≤25; Pre-onset modified Rankin Scale (mRS) score ≤1; Randomized and initiated transcranial magnetic stimulation within 1 week of onset; Subject or legal representative agreed to the treatment and signed the informed consent. Exclusion Criteria: Presence of a medical condition such as severe cognitive impairment or mental impairment; Patients with serious physical diseases or who have had craniocerebral surgery; Previous history of epilepsy, family history of epilepsy or presence of seizure provoking factors; Pregnancy or breastfeeding; The presence of metal foreign bodies near the stimulation site, such as intracranial metal implants, cochlear implants, built-in pulse generators (brain pacemakers, cardiac pacemakers), etc.; Patients who are unable to complete cerebral autoregulation, or bilateral temporal window penetration poorly; life expectancy of ≤3 months or inability to complete the study for other reasons; unwillingness to be followed up or poor treatment compliance; Those who are participating in other clinical investigators, or who have participated in other clinical studies within 3 months prior to enrollment, or who have participated in this study; Other conditions that the investigators deemed unsuitable for enrollment.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Active Comparator
Placebo Comparator
rTMS
sham-rTMS
Patients are treated with repetitive transcranial magnetic stimulation (rTMS).
Patients are treated with sham repetitive transcranial magnetic stimulation (sham-rTMS).